TÜBİTAK 1002 Project Support to Dr. İsmail AKÇOK

TÜBİTAK 1002 project titled "Investigation of the Anticancer Effect of Rapamycin and Niacin Combinations on Acute Myeloid Leukemia (AML) Cell Lines' has been approved under the leadership of our faculty member Dr. İsmail AKÇOK.